Lilly Positions India as Global Manufacturing Hub Amid Mounjaro Demand
Eli Lilly and Company is moving to position India as a strategic global manufacturing and export hub, supported by strong demand for its blockbuster diabetes and obesity therapy Mounjaro. A senior executive said the company is advancing plans to integrate India more deeply into its worldwide supply chain through contract manufacturing partnerships.
Global Manufacturing Hub | 18/02/2026 | By Darshana | 266
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy